Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells

D Belov Kirdajova, J Kriska, J Tureckova… - Frontiers in cellular …, 2020 - frontiersin.org
A plethora of neurological disorders shares a final common deadly pathway known as
excitotoxicity. Among these disorders, ischemic injury is a prominent cause of death and …

The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

E Pajarillo, A Rizor, J Lee, M Aschner, E Lee - Neuropharmacology, 2019 - Elsevier
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

Glial cells as therapeutic approaches in brain ischemia-reperfusion injury

IH Hernández, M Villa-González, G Martín, M Soto… - Cells, 2021 - mdpi.com
Ischemic stroke is the second cause of mortality and the first cause of long-term disability
constituting a serious socioeconomic burden worldwide. Approved treatments include …

Astrocytes in functional recovery following central nervous system injuries

QM Alhadidi, GA Bahader, O Arvola… - The Journal of …, 2024 - Wiley Online Library
Astrocytes are increasingly recognised as partaking in complex homeostatic mechanisms
critical for regulating neuronal plasticity following central nervous system (CNS) insults …

Crosstalk of astrocytes and other cells during ischemic stroke

T He, GY Yang, Z Zhang - Life, 2022 - mdpi.com
Stroke is a leading cause of death and long-term disability worldwide. Astrocytes structurally
compose tripartite synapses, blood–brain barrier, and the neurovascular unit and perform …

Current approaches to enhance glutamate transporter function and expression

ACK Fontana - Journal of neurochemistry, 2015 - Wiley Online Library
Abstract l‐glutamate is the predominant excitatory neurotransmitter in the CNS and has a
central role in a variety of brain functions. The termination of glutamate neurotransmission by …

Neuroprotective effects of emodin against ischemia/reperfusion injury through activating ERK-1/2 signaling pathway

SW Leung, JH Lai, JCC Wu, YR Tsai, YH Chen… - International journal of …, 2020 - mdpi.com
Background: Stroke is one of the leading causes of death and disability worldwide and
places a heavy burden on the economy in our society. Current treatments, such as the use of …

Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes

M Bacigaluppi, GL Russo… - Journal of …, 2016 - Soc Neuroscience
Ischemic stroke is the leading cause of disability, but effective therapies are currently widely
lacking. Recovery from stroke is very much dependent on the possibility to develop …

Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases

CLG Lin, Q Kong, GD Cuny… - Future medicinal …, 2012 - Taylor & Francis
Glutamate is the primary excitatory amino acid neurotransmitter in the CNS. The
concentration of glutamate in the synaptic cleft is tightly controlled by interplay between …

Role of the ubiquitin–proteasome system in brain ischemia: Friend or foe?

MV Caldeira, IL Salazar, M Curcio… - Progress in …, 2014 - Elsevier
The ubiquitin–proteasome system (UPS) is a catalytic machinery that targets numerous
cellular proteins for degradation, thus being essential to control a wide range of basic …